Do statins lower testosterone and does it matter?

por Sniderman, Allan D, Thanassoulis, George
Publicado 2013

Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyte

por Kiss, Robert Scott, Sniderman, Allan
Publicado 2017

Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National H...

por Ford, Earl S, Li, Chaoyang, Sniderman, Allan
Publicado 2013

Apolipoprotein B in cardiovascular risk assessment

por Ahmad, Maud, Sniderman, Allan D., Hegele, Robert A.
Publicado 2023

Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women

por Smith, Jessica, Al-Amri, Maha, Sniderman, Allan, Cianflone, Katherine
Publicado 2006

Mortality Benefit of Alirocumab: A Bayesian Perspective

por Labos, Christopher, Brophy, James M., Sniderman, Allan, Thanassoulis, George
Publicado 2019

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol

por Contois, John H., Langlois, Michel R., Cobbaert, Christa, Sniderman, Allan D.
Publicado 2023

Elevated troponin I levels but not low grade chronic inflammation is associated with cardiac-specific mortality in stable hemodialysis patients

por Alam, Ahsan, Palumbo, Andrea, Mucsi, Istvan, Barré, Paul E, Sniderman, Allan D
Publicado 2013

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated

por Sniderman, Allan D., Thanassoulis, George, Wilkins, John T., Furberg, Curt D., Pencina, Michael
Publicado 2018

Regulation of plasma LDL: the apoB paradigm

por Sniderman, Allan D., De Graaf, Jacqueline, Couture, Patrick, Williams, Ken, Kiss, Robert S., Watts, Gerald F.
Publicado 2009

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk...

por Glavinovic, Tamara, Thanassoulis, George, de Graaf, Jacqueline, Couture, Patrick, Hegele, Robert A., Sniderman, Allan D.
Publicado 2022

Diabetes, Abdominal Adiposity, and Atherogenic Dyslipoproteinemia in Women Compared With Men

por Williams, Ken, Tchernof, Andre, Hunt, Kelly J., Wagenknecht, Lynne E., Haffner, Steven M., Sniderman, Allan D.
Publicado 2008

The causal exposure model of vascular disease

por Sniderman, Allan D., Lawler, Patrick R., Williams, Ken, Thanassoulis, George, de Graaf, Jacqueline, Furberg, Curt D.
Publicado 2011

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol

por Sniderman, Allan D., Islam, Shofiqul, McQueen, Matthew, Pencina, Michael, Furberg, Curt D., Thanassoulis, George, Yusuf, Salim
Publicado 2016

A Comparison of Lipids and apoB in Asian Indians and Americans

por Singh, Kavita, Thanassoulis, George, Dufresne, Line, Nguyen, Albert, Gupta, Ruby, Narayan, KM Venkat, Tandon, Nikhil, Sniderman, Allan, Prabhakaran, Dorairaj
Publicado 2021

Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials

por Thanassoulis, George, Williams, Ken, Ye, Keying, Brook, Robert, Couture, Patrick, Lawler, Patrick R., de Graaf, Jacqueline, Furberg, Curt D., Sniderman, Allan
Publicado 2014

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

por Nelson, Adam J., Sniderman, Allan D., Ditmarsch, Marc, Dicklin, Mary R., Nicholls, Stephen J., Davidson, Michael H., Kastelein, John J. P.
Publicado 2022

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study

por Afshar, Mehdi, Rong, Jian, Zhan, Yang, Chen, Hao Yu, Engert, James C., Sniderman, Allan D., Larson, Martin G., Vasan, Ramachandran S., Thanassoulis, George
Publicado 2020

Effect of Selective Androgen Receptor Modulator on Cholesterol Efflux Capacity, Size, and Subspecies of HDL Particles

por Guo, Wen, Pencina, Karol M, Furtado, Jeremy D, Sacks, Frank M, Vaisar, Tomas, Cheng, Ming, Sniderman, Allan D, Page, Stephanie T, Bhasin, Shalender
Publicado 2022

Quantifying Importance of Major Risk Factors for Coronary Heart Disease

por Pencina, Michael J., Navar, Ann Marie, Wojdyla, Daniel, Sanchez, Robert J., Khan, Irfan, Elassal, Joseph, D’Agostino, Ralph B., Peterson, Eric D., Sniderman, Allan D.
Publicado 2019